pharmaceuticals-and-healthcare

United States Bio-pharma Market Report 2017


Published On : May 2017

Category : Pharmaceutical

No. of Pages : 109 pages

  • $3800
  • $7600

Please click below to avail discount on this report

In this report, the United States Bio-pharma market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Bio-pharma in these regions, from 2012 to 2022 (forecast).

United States Bio-pharma market competition by top manufacturers/players, with Bio-pharma sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Bio-pharma for each application, including
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

In the recent times, the global market for United states bio pharma market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states bio pharma market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states bio pharma market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states bio pharma market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states bio pharma market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states bio pharma market report 2017, including the definition, classification, and industry chain structure of United states bio pharma market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states bio pharma market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states bio pharma market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states bio pharma market report 2017, implemented in each of the geographical segments. The predominant applications of the United states bio pharma market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states bio pharma market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states bio pharma market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Bio-pharma
Figure United States Bio-pharma Market Size (K Pcs) by Type (2012-2022)
Figure United States Bio-pharma Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Recombinant Proteins Product Picture
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Figure Interferons Product Picture
Figure Recombinant Human Insulin Product Picture
Figure Erythropoietin Product Picture
Figure Vaccines Product Picture
Figure Growth Hormones Product Picture
Figure Purified Proteins Product Picture
Figure Others Product Picture
Figure United States Bio-pharma Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Bio-pharma by Application in 2016
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Neurological Disorders Examples
Table Key Downstream Customer in Neurological Disorders
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases Examples
Table Key Downstream Customer in Inflammatory and Infectious Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Bio-pharma Market Size (Million USD) by Region (2012-2022)
Figure The West Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Bio-pharma Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Bio-pharma Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Bio-pharma Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Bio-pharma Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Bio-pharma Sales Share by Players/Suppliers
Figure 2017 United States Bio-pharma Sales Share by Players/Suppliers
Figure United States Bio-pharma Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Bio-pharma Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Bio-pharma Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Bio-pharma Revenue Share by Players/Suppliers
Figure 2017 United States Bio-pharma Revenue Share by Players/Suppliers
Table United States Market Bio-pharma Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Bio-pharma Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Bio-pharma Market Share of Top 3 Players/Suppliers
Figure United States Bio-pharma Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Bio-pharma Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Bio-pharma Product Category
Table United States Bio-pharma Sales (K Pcs) by Region (2012-2017)
Table United States Bio-pharma Sales Share by Region (2012-2017)
Figure United States Bio-pharma Sales Share by Region (2012-2017)
Figure United States Bio-pharma Sales Market Share by Region in 2016
Table United States Bio-pharma Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Bio-pharma Revenue Share by Region (2012-2017)
Figure United States Bio-pharma Revenue Market Share by Region (2012-2017)
Figure United States Bio-pharma Revenue Market Share by Region in 2016
Table United States Bio-pharma Price (USD/Pcs) by Region (2012-2017)
Table United States Bio-pharma Sales (K Pcs) by Type (2012-2017)
Table United States Bio-pharma Sales Share by Type (2012-2017)
Figure United States Bio-pharma Sales Share by Type (2012-2017)
Figure United States Bio-pharma Sales Market Share by Type in 2016
Table United States Bio-pharma Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Bio-pharma Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bio-pharma by Type (2012-2017)
Figure Revenue Market Share of Bio-pharma by Type in 2016
Table United States Bio-pharma Price (USD/Pcs) by Types (2012-2017)
Figure United States Bio-pharma Sales Growth Rate by Type (2012-2017)
Table United States Bio-pharma Sales (K Pcs) by Application (2012-2017)
Table United States Bio-pharma Sales Market Share by Application (2012-2017)
Figure United States Bio-pharma Sales Market Share by Application (2012-2017)
Figure United States Bio-pharma Sales Market Share by Application in 2016
Table United States Bio-pharma Sales Growth Rate by Application (2012-2017)
Figure United States Bio-pharma Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Bio-pharma Sales Growth Rate (2012-2017)
Figure Pfizer Bio-pharma Sales Market Share in United States (2012-2017)
Figure Pfizer Bio-pharma Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Services Basic Information List
Table Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Revenue Market Share in United States (2012-2017)
Table Sanofi, Amgen Basic Information List
Table Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi, Amgen Bio-pharma Sales Growth Rate (2012-2017)
Figure Sanofi, Amgen Bio-pharma Sales Market Share in United States (2012-2017)
Figure Sanofi, Amgen Bio-pharma Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Bio-pharma Sales Growth Rate (2012-2017)
Figure AbbVie Bio-pharma Sales Market Share in United States (2012-2017)
Figure AbbVie Bio-pharma Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc Basic Information List
Table Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co., Inc Bio-pharma Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc Bio-pharma Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc Bio-pharma Revenue Market Share in United States (2012-2017)
Table Biogen Idec Basic Information List
Table Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Idec Bio-pharma Sales Growth Rate (2012-2017)
Figure Biogen Idec Bio-pharma Sales Market Share in United States (2012-2017)
Figure Biogen Idec Bio-pharma Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Bio-pharma Sales Growth Rate (2012-2017)
Figure Bayer AG Bio-pharma Sales Market Share in United States (2012-2017)
Figure Bayer AG Bio-pharma Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Bio-pharma Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Bio-pharma Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Bio-pharma Revenue Market Share in United States (2012-2017)
Table Novartis AG GlaxoSmithKline Plc Basic Information List
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Sales Growth Rate (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Sales Market Share in United States (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table AstraZeneca PLC Basic Information List
Table Abbott Laboratories Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bio-pharma
Figure Manufacturing Process Analysis of Bio-pharma
Figure Bio-pharma Industrial Chain Analysis
Table Raw Materials Sources of Bio-pharma Major Players/Suppliers in 2016
Table Major Buyers of Bio-pharma
Table Distributors/Traders List
Figure United States Bio-pharma Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Bio-pharma Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Bio-pharma Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Bio-pharma Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Bio-pharma Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Bio-pharma Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Bio-pharma Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Bio-pharma Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Bio-pharma Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Bio-pharma Sales Volume Share Forecast by Region (2017-2022)
Figure United States Bio-pharma Sales Volume Share Forecast by Region (2017-2022)
Figure United States Bio-pharma Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top